MORIMATSU INTL (02155) has canceled 2.074 million repurchased shares.

date
10/01/2025
avatar
GMT Eight
MORIMATSU INTL (02155) announced that on January 10, 2025, the company has cancelled 2,074,000 repurchased shares.
pre
The China Securities Regulatory Commission (CSRC) has approved New Asia Electric Cable's application for an initial public offering (IPO) on the Shenzhen Stock Exchange main board.
Harbin Pharmaceutical Group (600664.SH): The dextrose benzene sulfonate benzoate tablets produced by Harbin Pharmaceutical Group Factory Six have been discontinued in 2018. The related reports have confused the trademark name with the drug name.
next

RECOMMEND

recommend

UNI MEDICAL (02666) intends to issue corporate bonds with a total principal amount not exceeding 1 billion RMB.

date
10 min ago
recommend

U.S. Energy Corp. giant Constellation Energy (CEG.US) has agreed to acquire Calpine for 16.4 billion dollars.

date
12 min ago
recommend

HBM HOLDINGS-B (02142) and Collenbotech (06990) have entered into an exclusive licensing agreement with Windward Bio AG regarding HBM9378/SKB378.

date
13 min ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com